Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

Paclitaxel 95 Carboplatin 77 pembrolizumab 74 Cisplatin 29 Bevacizumab 27 Surveys and Questionnaires 23 Radiotherapy 22 Letrozole 22 Doxorubicin 21 Megestrol Acetate 20 olaparib 19 lenvatinib 19 Specimen Handling 18 Taxes 17 Magnetic Resonance Spectroscopy 17 Docetaxel 17 Nivolumab 16 dostarlimab 15 Metformin 15 Blood Specimen Collection 14 Observation 13 Gemcitabine 13 Biopsy 13 durvalumab 12 Medroxyprogesterone Acetate 12 Trastuzumab 11 Indocyanine Green 11 Fulvestrant 11 temsirolimus 10 abemaciclib 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Antineoplastic Agents, Hormonal × Gynecologic × Clear all

NCT03621904 2023-01-18

PROMOTE

Radboud University Medical Center

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡